Zacks.comEndocyte (ECYT) to Focus on Promising CAR-T Cell PlatformZacks.comIn Jun 2017, Endocyte announced plans to reduce its workforce by about 40% in order to divert more of its resources toward valuable opportunities The company also looks forward … Continue reading
Medscape |
FDA Panel Unanimously Recommends Approval for Novartis’ CAR T-Cell Therapy CTL019
Genetic Engineering & Biotechnology News Novartis is on track to win FDA approval later this year to market the first chimeric antigen receptor (CAR) T-cell therapy, following an advisory committee’s unanimous recommendation yesterday in favor of the company’s leukemia-fighting treatment … A New Dawn: First CAR T Cell Recommended for FDA ApprovalMedscape Novel cancer treatment wins endorsement of FDA advisersWashington Post FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer KillersFortune Drug Discovery & Development –ABC News –FDA –New York Times all 245 news articles » |
MIT Technology Review |
CRISPR ‘kill-switch’ wards off unwanted side effects
FierceBiotech CRISPR-Cas9 can neatly snip out disease-causing mutations from DNA, but comes with a question of safety—what if the system edits untargeted genes, bringing about harmful side effects? An anti-CRISPR protein that reduces off-target editing might be the … Scientists Used CRISPR to Put a GIF Inside a Living Organism’s DNAMIT Technology Review Lights, Cameras, CRISPR: Biologists Use Gene Editing to Store Movies in DNAScientific American Scientists Upload a Galloping Horse GIF Into Bacteria With CrisprWIRED The Atlantic –Alphr –Genetics –Science Magazine all 89 news articles » |
CNN |
‘Astounding’ second-chance cancer drug heading for FDA approval
CNN CAR–T drugs like tisagenlecleucel are made by removing immune cells from a patient, genetically modifying them using a virus and putting them back into the patient. The virus creates a new cell receptor — which is, in Novartis’ case, part mouse … |
Chicago Tribune |
First gene therapy — ‘a true living drug’ — on the cusp of FDA approval
Chicago Tribune If cleared by the FDA, it would be the first gene therapy approved in the United States. But unlike traditional gene therapy, the new treatment doesn’t replace disease-causing genes with healthy ones. Instead, it uses technology to reprogram immune … CAR-T gene therapy for leukemia clears FDA hurdleCBS News Did an FDA Panel Really Just Approve the First Gene Therapy Treatment?Gizmodo FDA Panel OKs First Gene Therapy For LeukemiaWebMD CNBC –USA TODAY –ABC News –FDA all 245 news articles » |
Asbestos.com |
Mesothelioma Clinical Trial Combines Immunotherapy Drugs
Asbestos.com Tanvetyanon is the principal investigator of a much-anticipated phase II clinical trial involving an immunotherapy drug combination with considerable potential for extending survival. “This is exciting. We now can offer something with realistic hope … |
Asbestos.com |
Mesothelioma Clinical Trial Combines Immunotherapy Drugs
Asbestos.com Tanvetyanon is the principal investigator of a much-anticipated phase II clinical trial involving an immunotherapy drug combination with considerable potential for extending survival. “This is exciting. We now can offer something with realistic hope … |